Table 1 Demographics and clinical data of study patients
From: Obesity paradox in patients undergoing lung lobectomy – myth or reality?
BMI < 30 (n = 133) | BMI ≥30 (n = 70) | p-value | Total (n = 203) | |
|---|---|---|---|---|
Age (years, mean ± SD) | 64.0 ± 9.2 | 65.2 ± 8.9 | 0.211 | 64.4 ± 9.1 |
Gender, n (%) | ||||
Female | 51 (38.4) | 26 (37.1) | 0.867 | 77 (37.9) |
Male | 82 (61.6) | 44 (62.9) | 126 (62.1) | |
BMI (kg/m2), mean ± SD) | 25.0 ± 3.4 | 34.1 ± 4.0 | < 0.001 | 28.2 ± 5.7 |
ASA, n (%) | ||||
I | 2 (1.5) | 2 (2.9) | 0.073 | 4 (2) |
II | 79 (59.4) | 32 (45.7) | 111 (54.6) | |
III | 48 (63.1) | 36 (51.4) | 84 (41.4) | |
IV | 4 (3) | 0 (0) | 4 (2) | |
Tumour size (cm, mean ± SD) | 3.8 ± 2.4 | 3.5 ± 1.9 | 0.092 | 3.7 ± 2.3 |
Histopathology findings, n (%) | ||||
Adenocarcinoma | 60 (45.1) | 25 (35.7) | 0.463 | 85 (41.9) |
Spinocellular carcinoma | 37 (27.8) | 27 (38.6) | 64 (31.5) | |
Neuroendocrine carcinoma | 5 (3.8) | 7 (10.0) | 12 (5.9) | |
Parvocellular carcinoma | 5 (3.8) | 1 (1.4) | 6 (3.0) | |
Sarcoma, Lymphoma | 3 (2.3) | 2 (2.8) | 5 (2.5) | |
Metastasis | 7 (5.3) | 1 (1.4) | 8 (3.9) | |
Benign lesion | 16 (12.0) | 7 (10.0) | 23 (11.3) | |